Introduction
Mortality among patients on dialysis has decreased over time, due mainly to advances in treatment; however, when compared to the general population, mortality is still very high in patients on dialysis. The mortality of patients on peritoneal dialysis (PD) in the United States decreased by 15% between 1993 and 2002, and 35% between 2003 and 2012 (1) .
Currently, in addition to the interest in increasing the survival time, there is also concern about how these patients experience the years aggregated with advances in treatment.
Peritoneal dialysis provides more flexibility in the treatment of patients with terminal chronic renal disease (CRD), as it can be performed at home by the patient himself and/or his caregiver. Some studies have demonstrated that this dialysis modality generally ensures greater satisfaction with treatment and less impact on the lives of patients, when compared with hemodialysis (2) . Peritoneal dialysis has been used for more than 30 years in Brazil; however, publications on the epidemiology and clinical experience in this type of treatment, as well as the number of patients who opt for it, are incipient (3) (4) .
The literature has described the losses observed in the health-related quality of life (HRQOL) of PD patients, due to CRD and its treatment (5) (6) .
The construct of quality of life (QOL) has received much attention in recent decades and, although there is no agreed definition, health researchers are interested in the aspects of QOL that are affected by diseases and treatments, therefore QOL assessment in this area is based on a person's self-perception regarding the impact on a number of important aspects and their ability to influence their health. Examples of these clinical and non-clinical aspects are: assessment of general health, physical health, mental/emotional state, social function, sexual function, aspects related to the disease, as well as indirect consequences such as unemployment and financial difficulties that converge to form a construct designated HRQOL (7) (8) .
The HRQOL has been identified as an important predictor of outcomes in the evolution of treatment, as well as a relevant factor in the choice of treatment by the patient (9) . The low HRQOL scores perceived by patients on dialysis have been reported as predictors of morbidity, hospitalization, and mortality (10) (11) (12) (13) .
The association between HRQOL and the outcome of death in patients on dialysis has been investigated in other countries, where the worst HRQOL scores have been found to be the main predictors of death (10, 14) .
Recently, in Brazil, this association was investigated in patients on HD and it was verified that the worst HRQOL, particularly in the physical functioning domain, could be considered a predictor of death (12) .
In this context, it is necessary to optimize the HRQOL of patients on dialysis, in addition to survival (3) .
The analysis of possible associations between HRQOL, socio-demographic, clinical and laboratory aspects, and the outcome of death can be useful in determining targeted areas for the planning of patient care, as well as providing support for further dissemination of this modality between new patients on dialysis. Therefore, this study aimed to characterize the deaths that occurred and the association between socio-demographic, clinical, laboratory, HRQOL and the outcome of death in patients on PD, over a period of two years, after an initial assessment.
Method
This was an observational, prospective population (15) , not hospitalized for acute complications or being treated for peritonitis.
After two years, the data on the occurrence of the outcome of death in the period, and the cause, were collected. There was a loss of six patients for followup due to: recovery of renal function (two) and county transfer (four). Therefore, of the 82 patients who were interviewed in 2010, 53 remained alive and 23 presented with the outcome of death, which was the target of analysis of the current study.
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In the first stage of data collection the instruments used were: MMSE (15) (16) in the translated version, adapted to the Brazilian culture and available to evaluate the HRQOL (17) . The KDQOL-SF where zero corresponds to the worst HRQOL and 100 the best HRQOL (17) .
Independent variables considered were: sex, age group, number of comorbidities, diabetes mellitus, systemic arterial hypertension (SAH), type of PD, results Censoring was defined as patients who did not have the outcome of death, during the period, and were included in the analysis (18) . The significance level was 5%.
Results
The With multivariate analysis, and use of the Cox proportional hazards model, it was possible to confirm the HRQOL dimension of physical functioning as a predictor of death. In the regression model presented in Table 2 , for every point of increase in the physical functioning dimension, the risk of death decreases by 1.8%, when adjusted for age group, treatment time, type of PD, and number of comorbidities.
*Health-related quality of life
The results of survival analysis confirmed the hypothesis that patients with worse scores of HRQOL, specifically in the physical functioning dimension,
showed an increased risk for the outcome of death.
Discussion
The HRQOL has also been investigated as a predictor of outcomes for patients in renal replacement therapy (RRT) (10) (11) (12) (13) (14) . Particularly in this study, the analysis of HRQOL and other variables of interest was performed, as predictors of the outcome of death for PD patients. The outcome of death was observed in 23 (30.3%) patients within two years after the initial evaluation. It is known that patients with terminal CRD in RRT have a lower survival rate when compared to the general population. Death was also reported as a major cause of discontinuation of dialysis treatment in another study conducted in Brazil with PD patients (19) .
Regarding the cause of death, there was a higher frequency of cardiovascular disease and infection, a result that corroborates the findings in other studies that evaluated patients on PD (10, 13) . There is a risk of unfavorable prognosis associated with cardiovascular disease in these patients, as well as the need to prevent infections, especially peritonitis, which is common in this dialysis modality. Rev. Latino-Am. Enfermagem 2016;24:e2687
The mean time of survival in PD for patients in this study was 23.4 months. In a survival analysis study conducted in Brazil, considering the initial treatment modality, a lower survival was observed in patients on PD that initiated RRT, who had a mean survival time of 28 months in a three-year follow-up (20) .
The risk factors for death, among others, were:
initiate dialysis with PD, female, having diabetes as a cause of CRD, being more than 55 years old when initiating treatment (20) . The characteristics of being an older woman and having diabetes were also common among the patients who died in this study.
The survival rate among the PD patients in this study was 69.7% over two years, similar to that found in a multicenter two year follow-up study conducted in
Brazil with PD patients, in which the observed survival rate was 70% (21) . Similar results were noted in the United States and Canada, in which two-year survival rates were 63.2% and 79.7%, respectively (22) .
In the exploratory analysis of the current study, observed risk factors for death were: diabetes, four or more comorbidities, and a mean score of less than 50
in the physical functioning dimension of the HRQOL. In the Kaplan-Meier curves, patients on CAPD and those with mean HRQOL scores of up to 50, in the physical functioning dimension, showed lower survival times.
It is common for patients with terminal CRD to accumulate comorbidities in addition to CRD throughout life. In addition to the impact in HRQOL observed from the comorbidities, impairment in the lives of patients that accumulate them has been observed in the literature. In the current study, patients with four or more comorbidities had a higher risk of having the outcome of death when compared to those with up to three comorbidities. The greatest risk calculated by the Klan comorbidity index was appointed as a predictor of mortality in a study conducted in Brazil with hemodialysis (HD), patients followed for two years (12) . It is noteworthy that patients with cardiovascular disease and diabetes had the lowest survival (23) (24) .
Diabetes, in particular, proved to be a risk for death in this study. The elderly patients on PD with cardiovascular disease and diabetes had the lowest survival in a study conducted in Brazil (23) . In a study of Canadian patients that sought to compare survival between patients on HD and PD, a lower survival was observed in elderly patients with diabetes on PD (24) .
The PD treatment can be administered in different ways, either manually or with a cycler to perform the exchange of dialysate, intermittently or continuously, that keeps the abdominal cavity either dry or wet during the day. The clinical condition and the lifestyle of the patient determine the type of PD (25) . Each type of PD has advantages and disadvantages, which therefore may impact differently on HRQOL and survival of patients.
The survival of CAPD patients was worse when compared to those in APD in the survival analysis, according to the Kaplan-Meier curve. However in the multivariate analysis using the Cox proportional hazards, the death risk did not differ in a statistically significant manner between patients on CAPD and APD.
In the international literature there were no significant differences in survival of patients who were treated by either type of PD. (26) .
Patients who had the outcome of death while receiving PD may not reflect a failure of technique alone, considering that due to the negative selection, many patients using this modality were elderly and also had several comorbidities (26) .
A study comparing the two instruments of the Physical Component Summary (PCS), the SF-36 and the SF-12, identified predictors of death in patients on dialysis, highlighted that physical functioning was one of the dimensions that made up the PCS (11) . In the current study, patients with a mean score of less than 50 points in the physical functioning dimension of HRQOL had a lower survival rate. Low scores on the PCS were also cited as predictors of lower survival in patients on PD (13) .
In a follow-up study of years with patients on HD, a strong association between the lowest mean scores in the three main KDQOL-SF™ components and lowest survival was found (10) . A worsening in the physical functioning dimension was also observed to be a predictor of lower survival, in a follow-up study conducted for two years with Brazilian patients on HD (12) . In a follow-up study of patients on HD observed for four years, a worsening in the summary of the physical and mental components of the SF-36 was noted over time, as well as an association with increased risk of death (14) .
The lowest HRQOL scores are an important risk for the outcome of death, so the measurement of HRQOL of RRT in patients cannot be neglected and should be routinely implemented in dialysis clinics and in patient follow-up (11) .
In accordance with the PD situation in Brazil, this study identified limitations that may have influenced the presented and discussed findings, but that could not be 
Conclusion
This study enabled us to verify that the lowest HRQOL, specifically in the physical functioning dimension, could be considered a predictor of death.
Thus, it is possible that a greater investment by the nurse in the functional rehabilitation and maintenance of patients can assist in improving aspects of HRQOL, especially in dimensions related to physical health, thus having a positive impact on the survival of patients on PD.
